FDA applicant
Ankon Technologies Co., Ltd.
FDA records 2 decisions for Ankon Technologies Co., Ltd. (Wuhan, CN) from 2022 to 2023: 1 510(k) clearance and 1 De Novo grant. Most are in product codes NEZ (System, Imaging, Gastrointestinal, Wireless…) and QZF (Gastrointestinal Capsule Endoscopy Analysis…). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Ankon Technologies Co., Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2022.
Planning a device like Ankon Technologies Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report